Aamund: Austerity affects CEOs as well
When the biotech company Bavarian had to abandon plans to find a partner for its Prostvac medicine last spring, it sent shockwaves through the stock market, and in just two hours the company share had dropped by over 30 %.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.